GP Flashcards
AF risk factors
HTN CCF Coronary artery disease Valvular disease Arrhythmias
Age DM Alcohol Male Smoking
AF presenting features
Palpitations Tachycardia Irregular pulse Stroke Dyspnoea Fatigue Chest pain Dizziness
AF investigations
ECG
TFTs
Echo
Before starting medication:
U+Es
CHA2DS2-VASc
AF ECG findings
Absent P waves
Irregularly irregular rate
AF echo findings
Valvular regurgitation or stenosis
LV or LA enlargement
PHTN
LV thickening and dysfunction
CHA2DS2-VASc
CHF - 1 HTN - 1 Age > 75 - 2 DM - 1 Stroke/TIA - 2 Vascular disease - 1 Age 65-74 - 1 Sex - Female
AF management
Anticoagulation - DOAC
- Factor 10a inhibitor
- CI in mitral stenosis or prosthetic valves
- Maintain INR 2-3
?Warfarin - HASBLED
Rate control - B-blocker
HASBLED
HTN - 1 Abnormal renal/liver function - 2 Stroke - 1 Bleeding history - 1 Labile INRs - 1 Elderly > 65 - 1 Drugs predisposing bleeding - 1
HTN definition
Clinical reading > 140/90
Ambulatory reading > 135/85
Primary hypertension = 90-95% of cases
Secondary HTN causes
Renal
- Glomerulonephritis
- Chronic pyelonephritis
- PKD
- Renal artery stenosis
Endocrine
- Primary hyperaldosteronism
- Phaeochromocytoma
- Cushing’s
- CAH
- Acromegaly
Other causes
- Glucocorticoids
- NSAIDs
- Pregnancy
- CoA
- COCP
HTN features
Usually asymptomatic
Headaches
Visual disturbances
Seizures
HTN investigations
24-hour BP monitoring
U+E - Check for cause or consequence HbA1c Lipids ECG Urine dip
HTN management
< 55 or DM2
- A
- A + D
- A + C + D
K+ < 4.5 - Spironolactone
K+ > 4.5 - A/B-blocker
HTN management
> 55 or Afro-Caribbean
- C
- C + A
- C + A + D
K+ < 4.5 - Spironolactone
K+ > 4.5 - A/B-blocker
ACE
Inhibits conversion of AT1 to AT2
Side effects
- Cough
- Angioedema
- Hyperkalaemia
Considerations
- CI in pregnancy
- Check renal function 2/3 weeks after starting
CCB
Block voltage-gated Ca channels
- Causes smooth muscle relaxation
- Reduces force of myocardial contraction
Side effects
- Flushing
- Ankle swelling
- Headache